NSDHL is present at higher protein levels in metastatic compared to non-metastatic breast cancer cell lines (102), and knockdown of NSDHL in metastatic BT-20 and MDA-MB-231 cells reduced cell viability, colony formation, and cell migration (102). Here, NSDHL is linked to breast cancer.